Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership176,077 shares
Latest Disclosed Value $ 4,102,594
Citadel Advisors Llc ownership in HVE / Innoviva, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 176,077 shares of Innoviva, Inc. (DE:HVE) valued at $3,521,540 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 178,314 shares of Innoviva, Inc.. This represents a change in shares of -1.25% during the quarter. The current value of the position is $3,380,678 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (HVE) in the form of stock options. The firm currently holds call options representing 18,400 of underlying shares valued at $428,720 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HVE / Innoviva, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVIVA COM 45781M101 176,077 -2,237 -1.25 4,103 15.10 0.0006
2026-02-17 2025-12-31 13F INNOVIVA COM 45781M101 178,314 -808,703 -81.93 3,564 -80.21 0.0005
2025-11-14 2025-09-30 13F INNOVIVA COM 45781M101 987,017 -451,226 -31.37 18,013 -37.66 0.0027
2025-08-14 2025-06-30 13F INNOVIVA COM 45781M101 1,438,243 714,488 98.72 28,894 120.21 0.0050
2025-05-15 2025-03-31 13F INNOVIVA COM 45781M101 723,755 407,639 128.95 13,122 139.26 0.0025
2025-02-14 2024-12-31 13F INNOVIVA COM 45781M101 316,116 -173,339 -35.41 5,485 -41.97 0.0009
2024-11-14 2024-09-30 13F INNOVIVA COM 45781M101 489,455 387,005 377.75 9,451 462.56 0.0018
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 102,450 26,263 34.47 1,680 44.70 0.0003
2024-05-15 2024-03-31 13F INNOVIVA COM 45781M101 76,187 32,089 72.77 1,161 552.25 0.0002
2024-02-14 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 44,098 -137,450 -75.71 179 -92.45 0.0000
2024-02-14 2023-12-31 13F INNOVIVA COM 45781M101 281,804 100,256 4,520 0.0008
2023-11-14 2023-09-30 13F INNOVIVA COM 45781M101 181,548 -423,002 -69.97 2,358 -58.19 0.0005
2023-08-14 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 604,550 120,164 24.81 5,640 31.13 0.0012
2023-08-14 2023-06-30 13F INNOVIVA COM 45781M101 732,407 -116,220 9,324 0.0019
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 484,386 -501,153 -50.85 4,301 -67.06 0.0009
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 848,627 -136,912 9,547 0.0021
2023-02-14 2022-12-31 13F INNOVIVA COM 45781M101 985,539 147,595 17.61 13,058 34.23 0.0031
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 837,944 237,602 39.58 9,728 9.78 0.0022
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 600,342 145,364 31.95 8,861 0.65 0.0023
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 454,978 420,636 1,224.84 8,804 1,384.65 0.0018
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 34,342 -356,537 -91.21 593 -90.92 0.0001
2021-11-15 2021-09-30 13F INNOVIVA Cmn 45781M101 390,879 168,057 75.42 6,532 118.61 0.0014
2021-08-16 2021-06-30 13F INNOVIVA COM 45781M101 222,822 -59,204 -20.99 2,988 -11.34 0.0007
2021-05-21 2021-03-31 13F/A-1 INNOVIVA COM 45781M101 282,026 5,085 1.84 3,370 -1.78 0.0008
2021-05-17 2021-03-31 13F INNOVIVA COM 45781M101 282,026 5,085 3,370 0.0008
2021-02-16 2020-12-31 13F INNOVIVA COM 45781M101 276,941 -90,151 -24.56 3,431 -10.56 0.0009
2020-11-16 2020-09-30 13F INNOVIVA COM 45781M101 367,092 124,689 51.44 3,836 13.19 0.0011
2020-08-14 2020-06-30 13F INNOVIVA Cmn 45781M101 242,403 -477,337 -66.32 3,389 -59.96 0.0012
2020-05-15 2020-03-31 13F INNOVIVA Cmn 45781M101 719,740 127,653 21.56 8,464 0.95 0.0038
2020-02-14 2019-12-31 13F INNOVIVA Cmn 45781M101 592,087 -232,596 -28.20 8,384 -3.54 0.0036
2019-11-14 2019-09-30 13F INNOVIVA Cmn 45781M101 824,683 517,911 168.83 8,692 94.58 0.0041
2019-08-14 2019-06-30 13F INNOVIVA Cmn 45781M101 306,772 5,060 1.68 4,467 5.53 0.0020
2019-05-15 2019-03-31 13F INNOVIVA Cmn 45781M101 301,712 159,016 111.44 4,233 70.00 0.0021
2019-02-14 2018-12-31 13F INNOVIVA Cmn 45781M101 142,696 142,696 2,490 0.0014
2018-11-13 2018-09-30 13F INNOVIVA Cmn 45781M101 0 -13,899 -100.00 0 -100.00
2018-08-14 2018-06-30 13F/A-1 INNOVIVA Cmn 45781M101 13,899 1,246 9.85 192 -9.00 0.0001
2018-08-10 2018-06-30 13F INNOVIVA Cmn 45781M101 13,899 1,246 192
2018-05-14 2018-03-31 13F/A-1 INNOVIVA Cmn 45781M101 12,653 -7,742 -37.96 211 -26.99 0.0001
2018-05-11 2018-03-31 13F INNOVIVA Cmn 45781M101 12,653 -7,742 211
2018-02-09 2017-12-31 13F INNOVIVA Cmn 45781M101 20,395 -140,061 -87.29 289 -87.25 0.0002
2017-11-09 2017-09-30 13F INNOVIVA Cmn 45781M101 160,456 116,623 266.06 2,266 303.92 0.0017
2017-08-11 2017-06-30 13F INNOVIVA Cmn 45781M101 43,833 -503,407 -91.99 561 -92.59 0.0005
2017-05-12 2017-03-31 13F INNOVIVA Cmn 45781M101 547,240 -145,747 -21.03 7,568 2.06 0.0069
2017-02-10 2016-12-31 13F INNOVIVA Cmn 45781M101 692,987 -87,796 -11.24 7,415 -13.58 0.0075
2017-01-31 2016-09-30 13F/A-1 INNOVIVA Cmn 45781M101 780,783 658,207 536.98 8,580 564.60 0.0086
2016-11-10 2016-09-30 13F INNOVIVA Cmn 45781M101 780,783 8,580
2017-01-31 2016-06-30 13F/A-1 INNOVIVA Cmn 45781M101 122,576 96,617 372.19 1,291 294.80 0.0014
2016-08-12 2016-06-30 13F INNOVIVA Cmn 45781M101 122,576 1,291
2017-01-31 2016-03-31 13F/A-1 INNOVIVA Cmn 45781M101 25,959 5,888 29.34 327 54.25 0.0004
2016-05-13 2016-03-31 13F INNOVIVA Cmn 45781M101 25,959 327
2017-01-31 2015-12-31 13F/A-1 THERAVANCE Cmn 88338T104 20,071 -90,857 -81.91 212 -73.37 0.0002
2016-02-12 2015-12-31 13F THERAVANCE INC. Cmn 88338T104 20,071 212
2015-11-16 2015-09-30 13F THERAVANCE INC. Cmn 88338T104 110,928 110,928 0.00 796 0.0008
2015-05-15 2015-03-31 13F THERAVANCE INC. Cmn 88338T104 0 -23,673 -100.00 0 -100.00
2015-02-17 2014-12-31 13F THERAVANCE INC. Cmn 88338T104 23,673 4,121 21.08 335 0.30 0.0004
2014-11-14 2014-09-30 13F THERAVANCE INC. Cmn 88338T104 19,552 -170,792 -89.73 334 -94.11 0.0004
2014-08-14 2014-06-30 13F THERAVANCE INC. Cmn 88338T104 190,344 12,103 6.79 5,668 2.77 0.0077
2014-05-15 2014-03-31 13F THERAVANCE INC. Cmn 88338T104 178,241 71,842 67.52 5,515 45.40 0.0076
2014-02-14 2013-12-31 13F THERAVANCE INC. Cmn 88338T104 106,399 -235,020 -68.84 3,793 -72.83 0.0049
2013-11-14 2013-09-30 13F THERAVANCE INC. Cmn 88338T104 341,419 140,721 70.12 13,961 80.54 0.0213
2013-08-14 2013-06-30 13F THERAVANCE INC. Cmn 88338T104 200,698 200,698 7,733 0.0134
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F INNOVIVA COM Call 18,400 -41.40 429 -31.74 n/a n/a n/a
2026-02-17 2025-12-31 13F INNOVIVA COM Call 31,400 628 n/a n/a n/a
2025-08-14 2025-06-30 13F INNOVIVA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F INNOVIVA COM Call 2,300 -80.00 42 -79.40 n/a n/a n/a
2025-02-14 2024-12-31 13F INNOVIVA COM Call 11,500 -8.73 200 -18.11 n/a n/a n/a
2024-11-14 2024-09-30 13F INNOVIVA COM Call 12,600 -37.00 243 -25.91 n/a n/a n/a
2024-08-14 2024-06-30 13F INNOVIVA COM Call 20,000 177.78 328 200.92 n/a n/a n/a
2024-05-15 2024-03-31 13F INNOVIVA COM Call 7,200 111.76 110 101.85 n/a n/a n/a
2024-02-14 2023-12-31 13F INNOVIVA COM Call 3,400 -81.42 55 -77.22 n/a n/a n/a
2024-02-14 2023-12-31 13F THESEUS PHARMACEUTICALS COM Call 4,000 16 n/a n/a n/a
2023-11-14 2023-09-30 13F INNOVIVA COM Call 18,300 -6.63 238 -4.82 n/a n/a n/a
2023-08-14 2023-06-30 13F INNOVIVA COM Call 19,600 226.67 250 271.64 n/a n/a n/a
2023-05-15 2023-03-31 13F INNOVIVA COM Call 6,000 -1.64 68 -16.25 n/a n/a n/a
2023-02-14 2022-12-31 13F INNOVIVA COM Call 6,100 -91.90 81 -90.85 n/a n/a n/a
2022-11-14 2022-09-30 13F INNOVIVA COM Call 75,300 -14.43 874 -32.72 n/a n/a n/a
2022-08-15 2022-06-30 13F INNOVIVA COM Call 88,000 5.39 1,299 -19.62 n/a n/a n/a
2022-05-16 2022-03-31 13F INNOVIVA COM Call 83,500 200.36 1,616 236.67 n/a n/a n/a
2022-02-14 2021-12-31 13F INNOVIVA COM Call 27,800 -35.50 480 -33.33 n/a n/a n/a
2021-11-15 2021-09-30 13F INNOVIVA Cmn Call 43,100 326.73 720 433.33 n/a n/a n/a
2021-08-16 2021-06-30 13F INNOVIVA COM Call 10,100 -30.82 135 -22.41 n/a n/a n/a
2021-05-21 2021-03-31 13F/A INNOVIVA COM Call 14,600 -9.88 174 -13.43 n/a n/a n/a
2021-05-17 2021-03-31 13F INNOVIVA COM Call 14,600 174 n/a n/a n/a
2021-02-16 2020-12-31 13F INNOVIVA COM Call 16,200 -26.03 201 -12.23 n/a n/a n/a
2020-11-16 2020-09-30 13F INNOVIVA COM Call 21,900 -44.42 229 -58.44 n/a n/a n/a
2020-08-14 2020-06-30 13F INNOVIVA Cmn Call 39,400 69.10 551 101.09 n/a n/a n/a
2020-05-15 2020-03-31 13F INNOVIVA Cmn Call 23,300 52.29 274 26.27 n/a n/a n/a
2020-02-14 2019-12-31 13F INNOVIVA Cmn Call 15,300 -39.53 217 -41.03 n/a n/a n/a
2019-08-14 2019-06-30 13F INNOVIVA Cmn Call 25,300 60.13 368 65.77 n/a n/a n/a
2019-05-15 2019-03-31 13F INNOVIVA Cmn Call 15,800 -84.45 222 -87.48 n/a n/a n/a
2019-02-14 2018-12-31 13F INNOVIVA Cmn Call 101,600 49.63 1,773 71.30 n/a n/a n/a
2018-11-13 2018-09-30 13F INNOVIVA Cmn Call 67,900 153.36 1,035 179.73 n/a n/a n/a
2018-08-14 2018-06-30 13F/A INNOVIVA Cmn Call 26,800 133.04 370 92.71 n/a n/a n/a
2018-08-10 2018-06-30 13F INNOVIVA Cmn Call 26,800 370 n/a n/a n/a
2018-05-14 2018-03-31 13F/A INNOVIVA Cmn Call 11,500 -46.76 192 -37.46 n/a n/a n/a
2018-05-11 2018-03-31 13F INNOVIVA Cmn Call 11,500 192 n/a n/a n/a
2018-02-09 2017-12-31 13F INNOVIVA Cmn Call 21,600 307 n/a n/a n/a
2017-11-09 2017-09-30 13F INNOVIVA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-11 2017-06-30 13F INNOVIVA Cmn Call 17,000 -1.73 218 -8.79 n/a n/a n/a
2017-05-12 2017-03-31 13F INNOVIVA Cmn Call 17,300 34.11 239 73.19 n/a n/a n/a
2017-02-10 2016-12-31 13F INNOVIVA Cmn Call 12,900 138 n/a n/a n/a
2016-05-13 2016-03-31 13F THERAVANCE INC. Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A THERAVANCE Cmn Call 18,600 -37.58 196 -8.41 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE INC. Cmn Call 18,600 196 n/a n/a n/a
2015-11-16 2015-09-30 13F THERAVANCE INC. Cmn Call 29,800 -35.78 214 -74.46 n/a n/a n/a
2015-08-14 2015-06-30 13F THERAVANCE Cmn Call 46,400 62.24 838 86.22 n/a n/a n/a
2015-05-15 2015-03-31 13F THERAVANCE Cmn Call 28,600 -50.00 450 -44.38 n/a n/a n/a
2015-02-17 2014-12-31 13F THERAVANCE INC. Cmn Call 57,200 9.37 809 -9.51 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE INC. Cmn Call 52,300 347.01 894 156.90 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE INC. Cmn Call 11,700 -69.77 348 -70.93 n/a n/a n/a
2014-05-15 2014-03-31 13F THERAVANCE INC. Cmn Call 38,700 -18.18 1,197 -29.00 n/a n/a n/a
2014-02-14 2013-12-31 13F THERAVANCE INC. Cmn Call 47,300 148.95 1,686 116.99 n/a n/a n/a
2013-11-14 2013-09-30 13F THERAVANCE INC. Cmn Call 19,000 -34.93 777 -30.93 n/a n/a n/a
2013-08-14 2013-06-30 13F THERAVANCE INC. Cmn Call 29,200 1,125 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F INNOVIVA COM Put 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F INNOVIVA COM Put 98,100 5.03 1,790 -4.58 n/a n/a n/a
2025-08-14 2025-06-30 13F INNOVIVA COM Put 93,400 3,791.67 1,876 4,262.79 n/a n/a n/a
2025-05-15 2025-03-31 13F INNOVIVA COM Put 2,400 200.00 44 230.77 n/a n/a n/a
2025-02-14 2024-12-31 13F INNOVIVA COM Put 800 166.67 14 160.00 n/a n/a n/a
2024-11-14 2024-09-30 13F INNOVIVA COM Put 300 -94.44 6 -94.32 n/a n/a n/a
2024-08-14 2024-06-30 13F INNOVIVA COM Put 5,400 -61.70 89 -58.88 n/a n/a n/a
2024-05-15 2024-03-31 13F INNOVIVA COM Put 14,100 0.00 215 275.44 n/a n/a n/a
2024-02-14 2023-12-31 13F THESEUS PHARMACEUTICALS COM Put 14,100 -12.42 57 -72.73 n/a n/a n/a
2024-02-14 2023-12-31 13F INNOVIVA COM Put 11,700 188 n/a n/a n/a
2023-11-14 2023-09-30 13F INNOVIVA COM Put 16,100 26.77 209 29.81 n/a n/a n/a
2023-08-14 2023-06-30 13F INNOVIVA COM Put 12,700 958.33 162 1,138.46 n/a n/a n/a
2023-05-15 2023-03-31 13F INNOVIVA COM Put 1,200 -76.00 14 -80.30 n/a n/a n/a
2023-02-14 2022-12-31 13F INNOVIVA COM Put 5,000 66 n/a n/a n/a
2022-08-15 2022-06-30 13F INNOVIVA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F INNOVIVA COM Put 14,700 284 n/a n/a n/a
2022-02-14 2021-12-31 13F INNOVIVA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F INNOVIVA Cmn Put 16,400 3.80 274 29.25 n/a n/a n/a
2021-08-16 2021-06-30 13F INNOVIVA COM Put 15,800 -25.47 212 -16.21 n/a n/a n/a
2021-05-21 2021-03-31 13F/A INNOVIVA COM Put 21,200 -21.48 253 -24.48 n/a n/a n/a
2021-05-17 2021-03-31 13F INNOVIVA COM Put 21,200 253 n/a n/a n/a
2021-02-16 2020-12-31 13F INNOVIVA COM Put 27,000 335 n/a n/a n/a
2020-11-16 2020-09-30 13F INNOVIVA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F INNOVIVA Cmn Put 10,900 -54.39 152 -45.91 n/a n/a n/a
2020-05-15 2020-03-31 13F INNOVIVA Cmn Put 23,900 65.97 281 37.75 n/a n/a n/a
2020-02-14 2019-12-31 13F INNOVIVA Cmn Put 14,400 -10.00 204 20.71 n/a n/a n/a
2019-11-14 2019-09-30 13F INNOVIVA Cmn Put 16,000 -47.54 169 -61.94 n/a n/a n/a
2019-08-14 2019-06-30 13F INNOVIVA Cmn Put 30,500 444 n/a n/a n/a
2018-11-13 2018-09-30 13F INNOVIVA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F/A INNOVIVA Cmn Put 35,800 130.97 494 91.47 n/a n/a n/a
2018-08-10 2018-06-30 13F INNOVIVA Cmn Put 35,800 494 n/a n/a n/a
2018-05-14 2018-03-31 13F/A INNOVIVA Cmn Put 15,500 49.04 258 74.32 n/a n/a n/a
2018-05-11 2018-03-31 13F INNOVIVA Cmn Put 15,500 258 n/a n/a n/a
2018-02-09 2017-12-31 13F INNOVIVA Cmn Put 10,400 148 n/a n/a n/a
2016-11-10 2016-09-30 13F INNOVIVA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-06-30 13F/A INNOVIVA Cmn Put 20,700 -21.29 218 -34.14 n/a n/a n/a
2016-08-12 2016-06-30 13F INNOVIVA Cmn Put 20,700 218 n/a n/a n/a
2017-01-31 2016-03-31 13F/A INNOVIVA Cmn Put 26,300 -4.71 331 13.75 n/a n/a n/a
2016-05-13 2016-03-31 13F INNOVIVA Cmn Put 26,300 331 n/a n/a n/a
2017-01-31 2015-12-31 13F/A THERAVANCE Cmn Put 27,600 411.11 291 646.15 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE INC. Cmn Put 27,600 291 n/a n/a n/a
2015-11-16 2015-09-30 13F THERAVANCE INC. Cmn Put 5,400 35.00 39 -45.83 n/a n/a n/a
2015-08-14 2015-06-30 13F THERAVANCE Cmn Put 4,000 -80.10 72 -77.22 n/a n/a n/a
2015-05-15 2015-03-31 13F THERAVANCE Cmn Put 20,100 -3.83 316 6.76 n/a n/a n/a
2015-02-17 2014-12-31 13F THERAVANCE INC. Cmn Put 20,900 -53.45 296 -61.41 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE INC. Cmn Put 44,900 490.79 767 239.38 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE INC. Cmn Put 7,600 -80.86 226 -81.60 n/a n/a n/a
2014-05-15 2014-03-31 13F THERAVANCE INC. Cmn Put 39,700 -16.77 1,228 -27.81 n/a n/a n/a
2014-02-14 2013-12-31 13F THERAVANCE INC. Cmn Put 47,700 10.42 1,701 -3.68 n/a n/a n/a
2013-11-14 2013-09-30 13F THERAVANCE INC. Cmn Put 43,200 -27.27 1,766 -22.85 n/a n/a n/a
2013-08-14 2013-06-30 13F THERAVANCE INC. Cmn Put 59,400 2,289 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.